知镜 Cognispect · 医学文献与研究工作台

[Efficacy evaluation of extracellular vesicle drug delivery system in orthotopic intravesical perfusion for bladder cancer].

Zheng M, Gao X, Liu J, Tan L, Song Y.
Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi · 2026-10-01 · PMID 42934144

文献摘要

To address the clinical challenges of limited therapeutic efficacy and pronounced toxicity associated with conventional intravesical chemotherapy due to the bladder mucosal barrier, this study constructs an extracellular vesicles (EVs)-based drug delivery system loaded with pirarubicin (THP), designated as EVs@THP. EVs derived from MB49 bladder tumor cells were extracted by ultracentrifugation and loaded with THP. Structural characterization confirmed that EVs@THP maintained stable vesicle structure. In vitro cell experiments showed that EVs@THP could be efficiently internalized by bladder cancer cells and presented stronger tumor killing ability compared with free THP. In vivo experiments using orthotopic bladder cancer mouse models further proved that EVs@THP possessed better tissue penetration and intravesical retention after perfusion, with significantly superior antitumor efficacy to free THP. MB49 cell-derived EVs are promising delivery carriers for THP. The EVs@THP system with good biocompatibility and targeting ability can effectively improve the outcome of bladder cancer intravesical chemotherapy, providing experimental evidence for the development and transformation of novel intravesical therapeutic regimens.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。